Juliana Idoyaga

13PUBLICATIONS
59CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 23, 2025
Bridging pDCs and cDCs: The Identity of Transitional Dendritic Cells.

Juliana Idoyaga, Hai Ni, Raul A Maqueda-Alfaro

|Oct 22, 2025
Thymic myeloid cells are heterogenous and include a novel population of transitional dendritic cells.

Matouš Vobořil, Fernando Bandeira Sulczewski, Ryan J Martinez

|Oct 14, 2025
Tonic type I interferon signaling optimizes the antiviral function of plasmacytoid dendritic cells.

Joseph N Pucella, Raul A Maqueda-Alfaro, Hai Ni

|Sep 05, 2025
Publisher Correction: TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells.

Rebeca Arroyo Hornero, Raul A Maqueda-Alfaro, Miguel A Solís-Barbosa

|Aug 12, 2025
TNF and type I interferon crosstalk controls the fate and function of plasmacytoid dendritic cells.

Rebeca Arroyo Hornero, Raul A Maqueda-Alfaro, Miguel A Solís-Barbosa

|Mar 27, 2025
CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy.

Sirimuvva Tadepalli, Derek R Clements, Hayley M Raquer-McKay

Pageof 3